(1) Zhang L, Li Y, Wu Z, Shen Q, Zeng C, Liu H, Zhang X, Yang J, Liu Q, Tang D, Ou K, Fa ng Y. Metrnl inhibits choroidal neovascularization by attenuating the choroidal inflammation via inactivating the UCHL-1/NF-κB signaling pathway. Front Immunol. 2024 Apr 30;15:137 9586. doi: 10.3389/fimmu.2024.1379586. PMID: 38745648; PMCID: PMC11091344.
(2) Fang Y, Wang Q, Zhang L, Xie L. SIPA1 promotes angiogenesis by regulating VEGF secretion in Müller cells through STAT3 activation. Heliyon. 2024 Jan 17;10(2):e24869. doi: 10.1016/j.heliyon.2024.e24869. PMID: 38312659; PMCID: PMC10834823.
(3) Fang Y, Wang Q, Li Y, Zeng L, Liu J, Ou K. On implications of somatostatin in diabetic retinopathy. Neural Regen Res. 2024 Sep 1;19(9):1984-1990. doi: 10.4103/1673-5374.390955. Epub 2023 Dec 15. PMID: 38227526; PMCID: PMC11040315.
(4) Wang Q, Zhang L, Shen Q, Zeng C, Fang Y, Ou K. 5-Bromo-3,4-dihydroxybenzaldehyde stabilizes diabetic retinal neurovascular units by inhibiting the inflammatory microenvironment. Biomed Pharmacother. 2023 Dec;168:115657. doi: 10.1016/j.biopha.2023.115657. Epub 2023 Oct 13. PMID: 37839106.
(5) Wang Q, Ou K, Zeng C, Fang Y. 5-Bromo-3,4-dihydroxybenzaldehyde attenuates endothelial cells injury from high glucose-induced damage. Biomed Pharmacother. 2022 Nov;155:113793. doi: 10.1016/j.biopha.2022.113793. Epub 2022 Oct 3. Erratum in: Biomed Pharmacother. 2024 May;174:116498. doi: 10.1016/j.biopha.2024.116498. PMID: 36271570.